Invention Grant
US08236760B2 Use of GLP-1 receptor agonists for the treatment of short bowel syndrome
有权
使用GLP-1受体激动剂治疗短肠综合征
- Patent Title: Use of GLP-1 receptor agonists for the treatment of short bowel syndrome
- Patent Title (中): 使用GLP-1受体激动剂治疗短肠综合征
-
Application No.: US12597892Application Date: 2008-04-24
-
Publication No.: US08236760B2Publication Date: 2012-08-07
- Inventor: Mark Pimentel , Edy E. Soffer , Jeffrey Conklin
- Applicant: Mark Pimentel , Edy E. Soffer , Jeffrey Conklin
- Applicant Address: US CA Los Angeles
- Assignee: Cedars-Sinsai Medical Center
- Current Assignee: Cedars-Sinsai Medical Center
- Current Assignee Address: US CA Los Angeles
- Agency: Nixon Peabody LLP
- Agent Linda B. Huber, Esq.
- International Application: PCT/US2008/061417 WO 20080424
- International Announcement: WO2008/134425 WO 20081106
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61K38/00
Abstract:
The present invention describes the methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders.
Public/Granted literature
- US20100137212A1 USE OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS Public/Granted day:2010-06-03
Information query
IPC分类:
